Omada Health Shares Jump
Digest more
Omada Health shows strong growth and innovation in chronic care but remains unprofitable with valuation, churn. See why OMDA stock is a hold.
The latest health news includes Texas seeing no new measles cases, Omada's successful stock market debut, South Africa's vaccination increase against foot-and-mouth disease, and bird flu ruled out in Brazil.
Omada Health shares popped more than 30% in their Nasdaq debut on Friday after the virtual chronic care company priced its stock at $19 per share in its IPO. The stock opened at $23 and quickly hit $25.